statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this applicationBRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot...

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Microbot Medical (NASDAQ:MBOT  Get Free Report) and Sigyn Therapeutics (OTCMKTS:SIGY  Get Free Report) are both small-cap medical companies, but which is the better investment? We will...

Head-To-Head Comparison: Microbot Medical (NASDAQ:MBOT) & Sigyn Therapeutics (OTCMKTS:SIGY)

Looking Into Microbot Medical's Recent Short Interest

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Microbot Medical announces settlement, release agreement

All of the cash payable to the plaintiffs in the settlement will be covered by Microbot's insurance carrier and will not impact company's cash positionBRAINTREE, Mass., Jan. 30, 2024 (GLOBE...

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical studyBRAINTREE, Mass., Jan. 18, 2024 (GLOBE...

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Microbot Medical (NASDAQ:MBOT  Get Free Report) and NeuroMetrix (NASDAQ:NURO  Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare...

Critical Analysis: Microbot Medical (NASDAQ:MBOT) vs. NeuroMetrix (NASDAQ:NURO)

Microbot Medical files to sell 1.77M shares of common stock for holders

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Braintree, MA.

Volume	31,899.00
52-Wk High	$4.44
52-Wk Low	$0.8601

MBOT Microbot Medical Inc

About

Feed

News

Sentiment

Fundamentals